Clinical Trial Update: Prazosin for Alcohol Use Disorder With Withdrawal Symptoms [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at Yale University is evaluating prazosin for alcohol use disorder with withdrawal symptoms and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Alcohol Withdrawal

Drugs mentioned

• Prazosin (prazosin)

Snippet

Sponsor: Yale University | Conditions: Alcohol Withdrawal | Phase 2 | Status: RECRUITING